NO973341D0 - Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for vasodilatorisk behandling eller profylakse - Google Patents

Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for vasodilatorisk behandling eller profylakse

Info

Publication number
NO973341D0
NO973341D0 NO973341A NO973341A NO973341D0 NO 973341 D0 NO973341 D0 NO 973341D0 NO 973341 A NO973341 A NO 973341A NO 973341 A NO973341 A NO 973341A NO 973341 D0 NO973341 D0 NO 973341D0
Authority
NO
Norway
Prior art keywords
preparation
diphenylchromanes
prophylaxis
vasodilatory
pharmaceutical preparation
Prior art date
Application number
NO973341A
Other languages
English (en)
Norwegian (no)
Other versions
NO973341L (no
Inventor
Michael Shalmi
Jan Ulrik Weis
Niels Korsgaard
Birgitte Hjort Guldhammer
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of NO973341L publication Critical patent/NO973341L/no
Publication of NO973341D0 publication Critical patent/NO973341D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO973341A 1995-01-20 1997-07-18 Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for vasodilatorisk behandling eller profylakse NO973341D0 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK6795 1995-01-20
DK77595 1995-06-30
PCT/DK1996/000013 WO1996022093A1 (en) 1995-01-20 1996-01-10 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for vasodilatory treatment or prophylaxis

Publications (2)

Publication Number Publication Date
NO973341L NO973341L (no) 1997-07-18
NO973341D0 true NO973341D0 (no) 1997-07-18

Family

ID=26063230

Family Applications (1)

Application Number Title Priority Date Filing Date
NO973341A NO973341D0 (no) 1995-01-20 1997-07-18 Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for vasodilatorisk behandling eller profylakse

Country Status (13)

Country Link
US (1) US5886021A (cs)
EP (1) EP0804188A1 (cs)
JP (1) JPH10513154A (cs)
KR (1) KR19980701548A (cs)
CN (1) CN1168100A (cs)
AU (1) AU4329196A (cs)
BR (1) BR9606767A (cs)
CA (1) CA2208852A1 (cs)
CZ (1) CZ211897A3 (cs)
HU (1) HUP9800297A3 (cs)
IL (1) IL116827A (cs)
NO (1) NO973341D0 (cs)
WO (1) WO1996022093A1 (cs)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101056868B (zh) 2004-09-21 2012-05-02 马休爱德华兹股份有限公司 取代的苯并二氢吡喃衍生物、药物及其在治疗中的应用
US8080675B2 (en) 2004-09-21 2011-12-20 Marshall Edwards, Inc. Chroman derivatives, medicaments and use in therapy
WO2012061409A1 (en) 2010-11-01 2012-05-10 Marshall Edwards, Inc. Isoflavonoid compounds and methods for the treatment of cancer
ES2643407T3 (es) 2014-02-07 2017-11-22 Novogen Ltd. Compuestos de benzopirano funcionalizados y uso de los mismos
PT3253208T (pt) 2015-02-02 2021-06-17 The Spanish National Cancer Res Centre Terapêuticas de combinação para utilização no tratamento do cancro da mama

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3340276A (en) * 1964-04-01 1967-09-05 Ciba Geigy Corp 3, 4-diphenyl-chromans
US3822287A (en) * 1969-04-17 1974-07-02 Rexall Drug Chemical Process for preparation of substituted 3,4-(diphenyl)chromans
US4447622A (en) * 1981-09-22 1984-05-08 Council Of Scientific And Industrial Research Rafi Marg Preparation of l- and d-isomers of dl-3,4-trans-2,2-disubstituted-3,4-diarylchromans and derivatives thereof
US5280040A (en) * 1993-03-11 1994-01-18 Zymogenetics, Inc. Methods for reducing bone loss using centchroman derivatives

Also Published As

Publication number Publication date
MX9705379A (es) 1997-10-31
BR9606767A (pt) 1997-12-30
CZ211897A3 (en) 1997-12-17
KR19980701548A (ko) 1998-05-15
CN1168100A (zh) 1997-12-17
JPH10513154A (ja) 1998-12-15
HUP9800297A2 (hu) 1998-12-28
IL116827A (en) 1999-11-30
WO1996022093A1 (en) 1996-07-25
AU4329196A (en) 1996-08-07
EP0804188A1 (en) 1997-11-05
NO973341L (no) 1997-07-18
IL116827A0 (en) 1996-05-14
US5886021A (en) 1999-03-23
HUP9800297A3 (en) 1999-12-28
CA2208852A1 (en) 1996-07-25

Similar Documents

Publication Publication Date Title
NO973243D0 (no) Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av gynekologiske sykdommer
NO961006L (no) Fosfonomononukleinsyrer, fremgangsmåter for fremstilling derav og anvendelse av forbindelsene
NO943888D0 (no) Farmasöytisk preparat
NL300258I2 (nl) Farmaceutische samenstelling voor toepassing in debehandeling van.
EE9700145A (et) Tsükloalkaanpüridiinid, nende valmistamismeetod, kasutamine ravimite tootmiseks ja nimetatud ühendeid sisaldavad ravimid
NO910828L (no) Preparat for behandling av erektil funksjonssvikt.
FI973828A0 (fi) Yhdisteitä ja koostumuksia aktiivisten aineiden annostelemiseksi
EE9700031A (et) Pürido-liitunud tienüül- ja furanüüloksasolidinoonid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja nimetatud ühendeid sisaldavad ravimid
FI921875A7 (fi) Menetelmä lääkeaineina käyttökelpoisten bentsisotiatsoli- ja bentsisoksatsoli-3-karboksiamidien valmistamiseksi
NO961742L (no) Anvendelse av retinoider i et kosmetisk preparat eller for fremstilling av et farmsöytisk preparat
EE03774B1 (et) 5-O-desosaminüül-6-O-metüülerütronoliid A derivaadid, nende valmistamismeetod ja kasutamine bioaktiivsete produktide valmistamiseks
NO981008D0 (no) Farmasöytisk formulering
EE9600172A (et) Puriin-6-ooni derivaadid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja ravimid
EE9600018A (et) 2,9-diasendatud puriin-6-oonid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja nimetatud ühendeid sisaldavad ravimid
FI971268A7 (fi) Menetelmä 1,3-alkaanidiolien ja 3-hydroksialdehydien valmistamiseksi
NO942303D0 (no) Farmasöytisk preparat, samt fremgangsmåte for fremstilling derav
FI941447A0 (fi) Suun kautta annettavat, kapseleina olevat ubidekarenonivalmisteet
NO20041007L (no) Anvendelse av oksypurin-nukleosider for fremstilling av et farmasoytisk preparat
EE200000226A (et) 3,6-poolketaalid 9a-asaliidide klassist, nende valmistamismeetod ja farmatseutiline kompositsioon
EE03878B1 (et) 5-O-desosaminüül-6-O-metüülerütronoliid A derivaadid, nende valmistamismeetod ja kasutamine bioaktiivsete ühendite valmistamiseks
NO973342D0 (no) Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av cerebrale degenerative sykdommer
FI961378A0 (fi) Menetelmä N-metyyli-3-(1-metyyli-4-piperidinyyli)-14-indoli-5-etaanisulfonamidin valmistamiseksi
NO973340D0 (no) Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av fedme
NO973242D0 (no) Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av idiopatisk eller fysiologisk gynekomasti
NO960529L (no) Substituerte benzensulfonylureaer og -tioureaer, fremgangsmåte for fremstilling av disse, og deres anvendelse for fremstilling av farmasöytiske preparater samt farmasöytiske preparater inneholdende forbindelsene